Elsevier

Heart Rhythm

Volume 6, Issue 6, June 2009, Pages 886-933
Heart Rhythm

News from the Heart Rhythm Society
Consensus document
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA)

https://doi.org/10.1016/j.hrthm.2009.04.030Get rights and content

Section snippets

Preamble

The purpose of this Consensus Statement is to provide a state-of-the-art review of the field of catheter ablation of ventricular tachycardia (VT), and to report the findings of a Task Force, convened by the European Heart Rhythm Association (EHRA) and the Heart Rhythm Society (HRS) that was charged with defining the indications, techniques, and outcomes of this procedure. This statement summarizes the opinion of the Task Force members based on their own experience in treating patients, as well

Table of Contents

  • I

    INTRODUCTION......887

  • II

    VENTRICULAR TACHYCARDIA: DEFINITIONS, MECHANISMS, AND RATIONALE FOR ABLATION......887

  • III

    INDICATIONS FOR CATHETER ABLATION OF VENTRICULAR TACHYCARDIA......891

  • IV

    TECHNICAL ASPECTS......891

  • V

    VENTRICULAR TACHYCARDIA IN STRUCTURAL HEART DISEASE......899

  • VI

    ABLATION OUTCOMES AND CONSIDERATIONS IN SPECIFIC DISEASES......908

  • VII

    IDIOPATHIC VENTRICULAR TACHYCARDIAS......913

  • VIII

    TRAINING AND INSTITUTIONAL REQUIREMENTS AND COMPETENCIES......916

  • IX

    CLINICAL TRIAL CONSIDERATIONS......918

  • X

    CONCLUSIONS......921

Definitions

Many terms have entered clinical usage to describe observations during mapping and ablation of VT. There has been substantial variation in the use of some terms by different investigators. The committee felt that these terms should be standardized to facilitate better understanding of methods, endpoints, and outcomes across centres (Table 1 and Figure 1).1, 2, 3, 4

Mechanisms and basis for catheter ablation of ventricular tachycardia

Monomorphic VT can occur in individuals with or without structural heart disease. The underlying heart disease and clinical

Indications for catheter ablation of ventricular tachycardia

Selection of catheter ablation for an individual patient should consider risks and benefits that are determined by patient characteristics, as well as the availability of appropriate facilities with technical expertise. In patients with structural heart disease, episodes of sustained VT are a marker for increased mortality and reduce quality of life in patients who have implanted defibrillators and structural heart disease.76, 77, 78, 79, 80 Antiarrhythmic medications can reduce the frequency

Technologies for mapping and ablation

Technological advances have been critical to the development of the field and will continue to play an important role in improving outcomes. The evaluation of new technologies has generally been based on uncontrolled series. There is limited head-to-head comparison of different technologies. Although new technologies generally increase the cost of a procedure when they are introduced, the costs may be justified if they improve outcomes.

The process of evaluation and adoption of new technologies

Ventricular tachycardia in structural heart disease

The most common cause of scar-related VT is a prior MI. The term non-ischaemic cardiomyopathy refers to all other causes of ventricular dysfunction. Myocardial fibrosis is almost always present in patients with non-ischaemic cardiomyopathies. However, the extent, location, and pattern of myocardial fibrosis vary greatly with the type of cardiomyopathy. Whereas most cardiomyopathic processes involve the LV predominantly, some, notably arrhythmogenic right ventricular dysplasia/cardiomyopathy

Prior myocardial infarction

Ventricular tachycardia occurs in 1–2% of patients late after MI, often after an interval of several years. Early reperfusion of infarct-related arteries results in less aneurysm formation, smaller scars, and less extensive electrophysiological abnormalities,311 although a significant risk of late VT (often with rapid cycle lengths) persists.312 In addition, the number of at-risk patients with chronic ischaemic cardiomyopathy due to multiple infarctions and late remodelling has increased due to

Idiopathic ventricular tachycardias

Idiopathic VT refers to VTs that occur in the absence of clinically apparent structural heart disease. These VTs occasionally occur in patients with structural heart disease, in whom the structural heart disease is not related to the VT. When frequent, they can be a cause of depressed ventricular function as a form of tachycardia-induced cardiomyopathy. Sudden death is rare, and therapy for idiopathic VTs is largely guided by symptoms. Ablation is a relatively effective option. Risks depend on

Training and institutional requirements and competencies

Catheter mapping and ablation in patients with potentially life-threatening ventricular arrhythmias is a challenging procedure that requires advanced technical and manual skills. Strategies, methods, and technology are evolving rapidly, and training and operator level requirements will change over time. Ventricular tachycardia ablation procedures should be performed in experienced, adequately equipped centres that have a dedicated electrophysiology programme that offers appropriate patient

Needs

Whereas several large randomized multicentre trials for ICD therapy assessing mortality have been performed, most knowledge of catheter ablation outcomes derives from single-centre studies. In most cases, these studies reflect the experience of large academic centres, the outcomes of which may or may not be replicated by smaller centres. The inherent design of such studies leave many questions unanswered. This section will address clinical trial considerations for the population of patients

Conclusions

Catheter ablation of VTs is increasingly performed. This document provides an up-to-date review of the indications, techniques, and outcomes. This statement summarizes the opinion of the task force members based on their analysis of the literature, as well as on their own experience in treating patients, and is directed to all healthcare professionals, healthcare institutions, manufacturers, and governmental, reimbursement, and regulatory bodies who are involved in the care of patients with

First page preview

First page preview
Click to open first page preview

References (464)

  • E. Downar et al.

    Ventricular tachycardia after surgical repair of tetralogy of Fallot: results of intraoperative mapping studies

    J Am Coll Cardiol

    (1992)
  • L.N. Horowitz et al.

    Electrophysiologic characteristics of sustained ventricular tachycardia occurring after repair of tetralogy of fallot

    Am J Cardiol

    (1980)
  • J.D. Kugler et al.

    Sustained ventricular tachycardia after repair of tetralogy of Fallot: new electrophysiologic findings

    Am J Cardiol

    (1983)
  • F. Ouyang et al.

    Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation

    J Am Coll Cardiol

    (2002)
  • J.M. de Bakker et al.

    Three-dimensional anatomic structure as substrate for ventricular tachycardia/ventricular fibrillation

    Heart Rhythm

    (2005)
  • F. Bogun et al.

    Isolated potentials during sinus rhythm and pace-mapping within scars as guides for ablation of post-infarction ventricular tachycardia

    J Am Coll Cardiol

    (2006)
  • H.H. Hsia et al.

    Anatomic characterization of endocardial substrate for hemodynamically stable reentrant ventricular tachycardia: identification of endocardial conducting channels

    Heart Rhythm

    (2006)
  • N. El-Sherif et al.

    Reentrant ventricular arrhythmias in the late myocardial infarction period12. Spontaneous versus induced reentry and intramural versus epicardial circuits

    J Am Coll Cardiol

    (1985)
  • P. Brugada et al.

    Continuous electrical activity during sustained monomorphic ventricular tachycardiaObservations on its dynamic behavior during the arrhythmia

    Am J Cardiol

    (1985)
  • J. Irvine et al.

    Quality of life in the Canadian Implantable Defibrillator Study (CIDS)

    Am Heart J

    (2002)
  • K. Soejima et al.

    Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars

    J Am Coll Cardiol

    (2004)
  • Y. Khaykin et al.

    Real-time integration of 2D intracardiac echocardiography and 3D electroanatomical mapping to guide ventricular tachycardia ablation

    Heart Rhythm

    (2008)
  • A. Arenal et al.

    Ablation of electrograms with an isolated, delayed component as treatment of unmappable monomorphic ventricular tachycardias in patients with structural heart disease

    J Am Coll Cardiol

    (2003)
  • A. Codreanu et al.

    Electroanatomic characterization of post-infarct scars comparison with 3-dimensional myocardial scar reconstruction based on magnetic resonance imaging

    J Am Coll Cardiol

    (2008)
  • A.E. Buxton et al.

    Right ventricular tachycardia: clinical and electrophysiologic characteristics

    Circulation

    (1983)
  • S. Ito et al.

    Development and validation of an ECG algorithm for identifying the optimal ablation site for idiopathic ventricular outflow tract tachycardia

    J Cardiovasc Electrophysiol

    (2003)
  • S. Kamakura et al.

    Localization of optimal ablation site of idiopathic ventricular tachycardia from right and left ventricular outflow tract by body surface ECG

    Circulation

    (1998)
  • B.B. Lerman et al.

    Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity

    Circulation

    (1986)
  • B.B. Lerman et al.

    Mechanism of repetitive monomorphic ventricular tachycardia

    Circulation

    (1995)
  • F. Morady et al.

    Long-term results of catheter ablation of idiopathic right ventricular tachycardia

    Circulation

    (1990)
  • R.J. Sung et al.

    Effects of beta-adrenergic blockade on verapamil-responsive and verapamil-irresponsive sustained ventricular tachycardias

    J Clin Invest

    (1988)
  • C. Antzelevitch et al.

    Cellular mechanisms underlying the long QT syndrome

    Curr Opin Cardiol

    (2002)
  • M. Haissaguerre et al.

    Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes

    Circulation

    (2003)
  • B.B. Lerman

    Response of nonreentrant catecholamine-mediated ventricular tachycardia to endogenous adenosine and acetylcholineEvidence for myocardial receptor-mediated effects

    Circulation

    (1993)
  • R.S. Damle et al.

    Radiofrequency catheter ablation of idiopathic left ventricular tachycardia originating in the left anterior fascicle

    Pacing Clin Electrophysiol

    (1998)
  • G. Lopera et al.

    Identification and ablation of three types of ventricular tachycardia involving the His-Purkinje system in patients with heart disease

    J Cardiovasc Electrophysiol

    (2004)
  • D.J. Huelsing et al.

    Spontaneous activity induced in rabbit Purkinje myocytes during coupling to a depolarized model cell

    Cardiovasc Res

    (2003)
  • K.W. Spitzer et al.

    Cell-to-cell electrical interactions during early and late repolarization

    J Cardiovasc Electrophysiol

    (2006)
  • E. Delacretaz et al.

    Mapping and radiofrequency catheter ablation of the three types of sustained monomorphic ventricular tachycardia in nonischemic heart disease

    J Cardiovasc Electrophysiol

    (2000)
  • R.E. Eckart et al.

    Sustained ventricular tachycardia associated with corrective valve surgery

    Circulation

    (2007)
  • H.H. Hsia et al.

    Electrophysiology studies in patients with dilated cardiomyopathies

    Card Electrophysiol Rev

    (2002)
  • M.E. Josephson et al.

    Recurrent sustained ventricular tachycardia1. Mechanisms

    Circulation

    (1978)
  • M.E. Josephson et al.

    Mechanisms of ventricular tachycardia

    Circulation

    (1987)
  • F.E. Marchlinski et al.

    Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy

    Circulation

    (2004)
  • E. Sosa et al.

    Endocardial and epicardial ablation guided by nonsurgical transthoracic epicardial mapping to treat recurrent ventricular tachycardia

    J Cardiovasc Electrophysiol

    (1998)
  • W.G. Stevenson et al.

    Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction

    Circulation

    (1993)
  • S.M. Dillon et al.

    Influences of anisotropic tissue structure on reentrant circuits in the epicardial border zone of subacute canine infarcts

    Circ Res

    (1988)
  • A.G. Kleber et al.

    Basic mechanisms of cardiac impulse propagation and associated arrhythmias

    Physiol Rev

    (2004)
  • J.M. de Bakker et al.

    Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation

    Circulation

    (1988)
  • N. El-Sherif et al.

    Canine ventricular arrhythmias in the late myocardial infarction period8. Epicardial mapping of reentrant circuits

    Circ Res

    (1981)
  • Cited by (487)

    View all citing articles on Scopus

    Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association, a registered branch of the European Society of Cardiology, the American Heart Association and the American College of Cardiology.

    View full text